Cargando…
Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection
Hyperinflammatory response caused by infections such as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) increases organ failure, intensive care unit admission, and mortality. Cytokine storm in patients with Coronavirus Disease 2019 (COVID-19) drives this pattern of poor clinical outcome...
Autores principales: | Creeden, Justin Fortune, Imami, Ali Sajid, Eby, Hunter M., Gillman, Cassidy, Becker, Kathryn N., Reigle, Jim, Andari, Elissar, Pan, Zhixing K., O’Donovan, Sinead M., McCullumsmith, Robert E., McCullumsmith, Cheryl B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904450/ https://www.ncbi.nlm.nih.gov/pubmed/33691249 http://dx.doi.org/10.1016/j.biopha.2021.111437 |
Ejemplares similares
-
Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example
por: Imami, Ali S., et al.
Publicado: (2021) -
Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach
por: O’Donovan, Sinead M., et al.
Publicado: (2021) -
SSRIs: Applications in inflammatory lung disease and implications for COVID‐19
por: Meikle, Claire Kyung Sun, et al.
Publicado: (2021) -
Subcellular partitioning of protein kinase activity revealed by functional kinome profiling
por: Wegman-Points, Lauren, et al.
Publicado: (2022) -
Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS
por: O’Donovan, Sinead M, et al.
Publicado: (2020)